156 related articles for article (PubMed ID: 32562275)
1. Cannabinoid type-2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL-1β stimulated primary human periodontal ligament fibroblasts.
Abidi AH; Alghamdi SS; Dabbous MK; Tipton DA; Mustafa SM; Moore BM
J Periodontal Res; 2020 Oct; 55(5):762-783. PubMed ID: 32562275
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts.
Abidi AH; Presley CS; Dabbous M; Tipton DA; Mustafa SM; Moore BM
Arch Oral Biol; 2018 Mar; 87():79-85. PubMed ID: 29274621
[TBL] [Abstract][Full Text] [Related]
3. Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts.
Abidi AH; Abhyankar V; Alghamdi SS; Tipton DA; Dabbous M
J Periodontal Res; 2022 Dec; 57(6):1127-1138. PubMed ID: 36070347
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids and inflammatory response in periodontal ligament cells.
Özdemir B; Shi B; Bantleon HP; Moritz A; Rausch-Fan X; Andrukhov O
PLoS One; 2014; 9(9):e107407. PubMed ID: 25226300
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of IL-23 p19 expression in human periodontal ligament fibroblasts by IL-1β via concurrent activation of the NF-κB and MAPKs/AP-1 pathways.
Zhu L; Wu Y; Wei H; Yang S; Zhan N; Xing X; Peng B
Cytokine; 2012 Oct; 60(1):171-8. PubMed ID: 22688014
[TBL] [Abstract][Full Text] [Related]
6. New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists.
Faúndez-Parraguez M; Alarcón-Miranda C; Cho YH; Pessoa-Mahana H; Gallardo-Garrido C; Chung H; Faúndez M; Pessoa-Mahana D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681877
[TBL] [Abstract][Full Text] [Related]
7. Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis.
Gui H; Liu X; Wang ZW; He DY; Su DF; Dai SM
Rheumatology (Oxford); 2014 May; 53(5):802-9. PubMed ID: 24440992
[TBL] [Abstract][Full Text] [Related]
8. A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.
Correa F; Docagne F; Mestre L; Clemente D; Hernangómez M; Loría F; Guaza C
Biochem Pharmacol; 2009 Jan; 77(1):86-100. PubMed ID: 18848818
[TBL] [Abstract][Full Text] [Related]
9. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB
Cruz SL; Sánchez-Miranda E; Castillo-Arellano JI; Cervantes-Villagrana RD; Ibarra-Sánchez A; González-Espinosa C
Int Immunopharmacol; 2018 Nov; 64():298-307. PubMed ID: 30243065
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability.
Harvey BS; Nicotra LL; Vu M; Smid SD
Cytokine; 2013 Aug; 63(2):209-17. PubMed ID: 23706402
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition.
Nakajima Y; Furuichi Y; Biswas KK; Hashiguchi T; Kawahara K; Yamaji K; Uchimura T; Izumi Y; Maruyama I
FEBS Lett; 2006 Jan; 580(2):613-9. PubMed ID: 16406050
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressive effect of the endocannabinoid system on the inflammatory phenotypes of macrophages and mesenchymal stromal cells: a comparative study.
Ruhl T; Corsten C; Beier JP; Kim BS
Pharmacol Rep; 2021 Feb; 73(1):143-153. PubMed ID: 33026642
[TBL] [Abstract][Full Text] [Related]
13. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid Receptor-2 Activation in Keratinocytes Contributes to Elevated Peripheral β-Endorphin Levels in Patients With Obstructive Jaundice.
Tao K; Zhu J; Wei K; Meng X; Zhu M; Tao Y; Lu Z; Yu W
Anesth Analg; 2021 Jul; 133(1):251-262. PubMed ID: 33560661
[TBL] [Abstract][Full Text] [Related]
15. Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system.
Martín-Sánchez A; Warnault V; Montagud-Romero S; Pastor A; Mondragón N; De La Torre R; Valverde O
Pharmacol Biochem Behav; 2019 Aug; 183():22-31. PubMed ID: 31220547
[TBL] [Abstract][Full Text] [Related]
16. Functional CB2 type cannabinoid receptors at CNS synapses.
Morgan NH; Stanford IM; Woodhall GL
Neuropharmacology; 2009 Sep; 57(4):356-68. PubMed ID: 19616018
[TBL] [Abstract][Full Text] [Related]
17. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis.
Szilagyi JT; Composto-Wahler GM; Joseph LB; Wang B; Rosen T; Laskin JD; Aleksunes LM
Pharmacol Res; 2019 Mar; 141():331-342. PubMed ID: 30610963
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the endocannabinoid system in periodontal healing.
Kozono S; Matsuyama T; Biwasa KK; Kawahara K; Nakajima Y; Yoshimoto T; Yonamine Y; Kadomatsu H; Tancharoen S; Hashiguchi T; Noguchi K; Maruyama I
Biochem Biophys Res Commun; 2010 Apr; 394(4):928-33. PubMed ID: 20233580
[TBL] [Abstract][Full Text] [Related]
19. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
[TBL] [Abstract][Full Text] [Related]
20. IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathways.
Zhu L; Wu Y; Wei H; Xing X; Zhan N; Xiong H; Peng B
Mol Immunol; 2011 Jan; 48(4):647-56. PubMed ID: 21145111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]